The role of chidamide in the treatment of B-cell non-Hodgkin lymphoma: An updated systematic review

B-cell non-Hodgkin lymphoma (B-NHL) is a lymphoid malignancy derived from B-cells that remains difficult to treat. Moreover, relapses and refractory cases are common. Abnormalities in epigenetic mechanisms, such as imbalanced histone acetylation affecting certain genes, contribute to relapses and re...

Full description

Bibliographic Details

Published in:	Biomolecules & Biomedicine
Main Authors:	Hastono Ridwansyah, Indra Wijaya, Muhammad Hasan Bashari, Achmad Hussein Sundawa Kartamihardja, Bethy Suryawathy Hernowo
Format:	Article
Language:	English
Published:	Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023-09-01
Subjects:	Chidamide tucidinostat histone deacetylase (HDAC) histone deacetylase inhibitors non-Hodgkin lymphoma (NHL)
Online Access:	https://www.bjbms.org/ojs/index.php/bjbms/article/view/8791